Abrdn Life Sciences Investors (HQL) shares outstanding
Abrdn Life Sciences Investors (HQL) had 30.68M diluted shares on average in fiscal 2025 (the year ended September 30, 2025). That is 9.3% higher than the 28.06M of fiscal 2024. Figures as of 18 Nov 2026, 12:06 UTC, from Yahoo Finance.
Key facts
- Shares outstanding, fiscal 2025
- 30.68M
- Change on fiscal 2024
- +9.3%
- Highest on record
- 30.68Mfiscal 2025
- Lowest on record
- 24.55Mfiscal 2022
- Fiscal years on record
- 42022–2025
Figures as of . Statements from Yahoo Finance. Figures, not advice.
Abrdn Life Sciences Investors shares outstanding, in more detail
Across the 4 fiscal years on record (2022–2025), the highest was 30.68M in fiscal 2025 and the lowest 24.55M in fiscal 2022.
Shares outstanding by fiscal year
Abrdn Life Sciences Investors shares outstanding, year by year
| Fiscal year | Shares outstanding | Change | Year ended |
|---|---|---|---|
| 2025 | 30.68M | 9.3% up | |
| 2024 | 28.06M | 0.8% down | |
| 2023 | 28.29M | 15.2% up | |
| 2022 | 24.55M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.
How to read it
A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.
Abrdn Life Sciences Investors, figure by figure
- Abrdn Life Sciences Investors market cap
- Abrdn Life Sciences Investors revenue
- Abrdn Life Sciences Investors earnings
- Abrdn Life Sciences Investors earnings per share (EPS)
- Abrdn Life Sciences Investors P/E ratio
- Abrdn Life Sciences Investors P/S ratio
- Abrdn Life Sciences Investors P/B ratio
- Abrdn Life Sciences Investors free cash flow
- Abrdn Life Sciences Investors operating margin
- Abrdn Life Sciences Investors dividend
- Abrdn Life Sciences Investors total debt
- Abrdn Life Sciences Investors cash on hand
- Abrdn Life Sciences Investors total assets
- Abrdn Life Sciences Investors return on equity (ROE)
- Abrdn Life Sciences Investors return on invested capital (ROIC)
Abrdn Life Sciences Investors (HQL) overview: price, valuation and scorecard
Abrdn Life Sciences Investors shares outstanding: questions and answers
How many shares does Abrdn Life Sciences Investors have?
Abrdn Life Sciences Investors (HQL) had 30.68M diluted shares on average in fiscal 2025 (the year ended September 30, 2025). That is 9.3% higher than the 28.06M of fiscal 2024.
What are the highest and lowest diluted share count figures on record for Abrdn Life Sciences Investors?
Across the 4 fiscal years on record (2022–2025), the highest was 30.68M in fiscal 2025 and the lowest 24.55M in fiscal 2022.
How is Abrdn Life Sciences Investors's diluted share count calculated?
The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Abrdn Life Sciences Investors it is on record here for 4 fiscal years, 2022 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: shares outstanding
All stocks guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Abrdn Life Sciences Investors (HQL) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/HQL/shares-outstanding
Underlying data: Yahoo Finance.